Page last updated: 2024-08-23

1-deoxynojirimycin and leptin

1-deoxynojirimycin has been researched along with leptin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Butters, TD; Dwek, RA; Platt, FM; Priestman, DA; van der Spoel, AC	1
Goto, M; Hariya, N; Mochizuki, K; Osonoi, T; Saito, M	1

Trials

1 trial(s) available for 1-deoxynojirimycin and leptin

Article	Year
Add-on therapy with anagliptin in Japanese patients with type-2 diabetes mellitus treated with metformin and miglitol can maintain higher concentrations of biologically active GLP-1/total GIP and a lower concentration of leptin. Peptides, 2016, Volume: 86 Topics: 1-Deoxynojirimycin; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Leptin; Male; Metformin; Middle Aged; Pyrimidines; Treatment Outcome	2016

Article

Year

Add-on therapy with anagliptin in Japanese patients with type-2 diabetes mellitus treated with metformin and miglitol can maintain higher concentrations of biologically active GLP-1/total GIP and a lower concentration of leptin.

Peptides, 2016, Volume: 86

Topics: 1-Deoxynojirimycin; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Leptin; Male; Metformin; Middle Aged; Pyrimidines; Treatment Outcome

2016

Other Studies

1 other study(ies) available for 1-deoxynojirimycin and leptin

Article	Year
N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice. Diabetes, obesity & metabolism, 2008, Volume: 10, Issue:2 Topics: 1-Deoxynojirimycin; Adipose Tissue; Animals; Appetite Regulation; Enzyme Inhibitors; Leptin; Mice; Mice, Obese; Obesity; Weight Loss	2008